Ftse Mib
33.739,90
-0,08%
DAX
19.848,77
-0,34%
S&P 500
5.974,07
0,73%
NASDAQ
19.764,89
0,98%
Bitcoin
94.309,63
-0,40%
Pepperstone
Advertisement
Registration Strip Icon for alerts Registrati per avvisi in tempo reale, portafoglio personalizzato e movimenti di mercato.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NYSE Artivion Inc (AORT) Artivion Inc (AORT) Notizie

Artivion Inc

AORT
28,28
-0,20 (-0,70%)
24 Dic 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NYSE
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
23/12/202422:04EDGAR2Form 8-K - Current report
13/12/202421:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/12/202423:04EDGAR2Form 144 - Report of proposed sale of securities
12/12/202422:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/12/202422:59EDGAR2Form 144 - Report of proposed sale of securities
10/12/202421:45EDGAR2Form 4/A - Statement of changes in beneficial ownership of..
09/12/202421:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/12/202414:05EDGAR2Form 8-K - Current report
09/12/202414:00PRNUSArtivion Granted FDA Humanitarian Device Exemption for the..
09/12/202413:00EDGAR2Form 8-K - Current report
04/12/202422:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/12/202422:02EDGAR2Form 144 - Report of proposed sale of securities
08/11/202421:10EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/11/202420:17EDGAR2Form SC 13G/A - Statement of Beneficial Ownership by Certain..
08/11/202416:29EDGAR2Form SC 13G/A - Statement of Beneficial Ownership by Certain..
07/11/202422:05PRNUSArtivion Reports Third Quarter 2024 Financial Results
05/11/202422:15PRNUSArtivion to Participate in Upcoming Investor Conferences
24/10/202422:15PRNUSArtivion Announces Release Date and Teleconference Call..
10/10/202422:10PRNUSArtivion Announces Presentation of Late-Breaking Clinical..
03/10/202400:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/10/202422:25EDGAR2Form 144 - Report of proposed sale of securities
27/8/202422:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/8/202423:08EDGAR2Form 144 - Report of proposed sale of securities
19/8/202422:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/8/202422:44EDGAR2Form 144 - Report of proposed sale of securities
16/8/202417:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/8/202423:30EDGAR2Form 144 - Report of proposed sale of securities
15/8/202416:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/8/202420:33EDGAR2Form 144 - Report of proposed sale of securities
09/8/202417:47EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/8/202422:06EDGAR2Form 8-K - Current report
08/8/202422:05PRNUSArtivion Reports Second Quarter 2024 Financial Results
05/8/202422:10PRNUSArtivion to Participate in Upcoming Investor Conferences
25/7/202422:10PRNUSArtivion Announces Release Date and Teleconference Call..
01/7/202422:05PRNUSArtivion Amends Agreements with Endospan
03/6/202414:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/6/202414:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/6/202414:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/6/202414:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/6/202414:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/6/202414:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/6/202414:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/6/202414:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/5/202422:12EDGAR2Form SD - Specialized disclosure report
17/5/202422:14EDGAR2Form 8-K - Current report
16/5/202423:05EDGAR2Form 8-K - Current report
14/5/202400:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/5/202400:04EDGAR2Form 144 - Report of proposed sale of securities
10/5/202423:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/5/202423:53EDGAR2Form 144 - Report of proposed sale of securities
Apertura: 28,32 Min: 28,03 Max: 28,60
Chiusura: 28,48

La tua Cronologia

NYSE
AORT
Artivion
BIT
VDST
Vanguard Us Tsy 0-1 Yr B...
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network